Daniel Link, MD

Medical School Department Internal Medicine
Research Program Hematopoietic Development & Malignancy
Daniel Link

Researcher Background

Primary Academic Title

Deputy Director, Alvin J. Siteman Cancer Center; Chief, Division of Oncology; Alan A. and Edith L. Wolff Professor of Medicine, Division of Oncology, WashU Medicine

Training

  • 1985 - 1988: Intern and Resident, Internal Medicine, WashU Medicine, St. Louis, MO
  • 1988 - 1992: Fellow, Hematology/Oncology, WashU Medicine, St. Louis, MO

Education

  • 1985: MD, University of Wisconsin, Madison, WI

Research & Selected Publications

Research Interest

Molecular mechanisms controlling hematopoietic cell proliferation and differentiation; granulocyte colony stimulating factor receptor signal transduction and biological activities

Research Publications

Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AML.
Authors:

Baeten JT, Agashe S, Tabet I, one or more additional authors omitted Link DC

Journal & Year:

Blood Adv • 2026

A clinical guide to TP53 mutations in myeloid neoplasms.
Authors:

Urrutia S, Wong TN, Link DC

Journal & Year:

Blood • 2025

Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy.
Authors:

Liu J, Tran D, Xue L, one or more additional authors omitted Link DC, one or more additional authors omitted Bolton KL

Journal & Year:

Nat Genet • 2025

How chemotherapy shapes hematopoietic stem cells.
Authors:

Wong TN, Link DC

Journal & Year:

Nat Genet • 2025

ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.
Authors:

Sande CM, Chen S, Mitchell DV, one or more additional authors omitted Link DC, one or more additional authors omitted Babushok DV

Journal & Year:

J Clin Invest • 2025

Are TP53 mutations all alike?
Authors:

Wong TN, Link DC

Journal & Year:

Hematology Am Soc Hematol Educ Program • 2024

The Clonal Hematopoiesis-associated Gene Srcap Plays an Essential Role in Hematopoiesis.
Authors:

Wong TN, Mychalowych A, Feldpausch ER, one or more additional authors omitted Link DC

Journal & Year:

bioRxiv • 2024

Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.
Authors:

Tran D, Beeler JS, Liu J, one or more additional authors omitted Link DC, one or more additional authors omitted Bolton KL

Journal & Year:

Clin Cancer Res • 2024